Logo image of EVGN

EVOGENE LTD (EVGN) Stock Price, Quote, News and Overview

NASDAQ:EVGN - Nasdaq - IL0011050551 - Common Stock - Currency: USD

1.48  +0.07 (+4.94%)

After market: 1.49 +0.01 (+0.68%)

EVGN Quote, Performance and Key Statistics

EVOGENE LTD

NASDAQ:EVGN (3/7/2025, 8:22:32 PM)

After market: 1.49 +0.01 (+0.68%)

1.48

+0.07 (+4.94%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High9.28
52 Week Low1.2
Market Cap7.95M
Shares5.37M
Float5.28M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-21 2025-05-21/bmo
IPO06-11 2007-06-11


EVGN short term performance overview.The bars show the price performance of EVGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

EVGN long term performance overview.The bars show the price performance of EVGN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EVGN is 1.48 USD. In the past month the price decreased by -5.13%. In the past year, price decreased by -84.09%.

EVOGENE LTD / EVGN Daily stock chart

EVGN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.17 378.30B
AMGN AMGEN INC 16.39 174.51B
GILD GILEAD SCIENCES INC 25.47 146.22B
VRTX VERTEX PHARMACEUTICALS INC 1683.76 125.39B
REGN REGENERON PHARMACEUTICALS 15.5 77.34B
ARGX ARGENX SE - ADR 231.21 36.10B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.66B
ONC BEIGENE LTD-ADR N/A 26.47B
BNTX BIONTECH SE-ADR N/A 26.08B
BIIB BIOGEN INC 9.13 22.01B
NTRA NATERA INC N/A 19.02B
GMAB GENMAB A/S -SP ADR 24.89 15.34B

About EVGN

Company Profile

EVGN logo image Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Company Info

EVOGENE LTD

13 Gad Feinstein Street, Park Rehovot

Rehovot 7414002 IL

CEO: Ofer Haviv

Employees: 142

Company Website: https://evogene.com/

Investor Relations: http://investors.evogene.com/

Phone: 97289311900

EVOGENE LTD / EVGN FAQ

What is the stock price of EVOGENE LTD today?

The current stock price of EVGN is 1.48 USD. The price increased by 4.94% in the last trading session.


What is the ticker symbol for EVOGENE LTD stock?

The exchange symbol of EVOGENE LTD is EVGN and it is listed on the Nasdaq exchange.


On which exchange is EVGN stock listed?

EVGN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for EVOGENE LTD stock?

8 analysts have analysed EVGN and the average price target is 8.29 USD. This implies a price increase of 459.97% is expected in the next year compared to the current price of 1.48. Check the EVOGENE LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EVOGENE LTD worth?

EVOGENE LTD (EVGN) has a market capitalization of 7.95M USD. This makes EVGN a Nano Cap stock.


How many employees does EVOGENE LTD have?

EVOGENE LTD (EVGN) currently has 142 employees.


What are the support and resistance levels for EVOGENE LTD (EVGN) stock?

EVOGENE LTD (EVGN) has a support level at 1.35 and a resistance level at 1.49. Check the full technical report for a detailed analysis of EVGN support and resistance levels.


Is EVOGENE LTD (EVGN) expected to grow?

The Revenue of EVOGENE LTD (EVGN) is expected to grow by 38.71% in the next year. Check the estimates tab for more information on the EVGN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EVOGENE LTD (EVGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EVOGENE LTD (EVGN) stock pay dividends?

EVGN does not pay a dividend.


When does EVOGENE LTD (EVGN) report earnings?

EVOGENE LTD (EVGN) will report earnings on 2025-05-21, before the market open.


What is the Price/Earnings (PE) ratio of EVOGENE LTD (EVGN)?

EVOGENE LTD (EVGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.11).


What is the Short Interest ratio of EVOGENE LTD (EVGN) stock?

The outstanding short interest for EVOGENE LTD (EVGN) is 0.3% of its float. Check the ownership tab for more information on the EVGN short interest.


EVGN Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to EVGN. When comparing the yearly performance of all stocks, EVGN is a bad performer in the overall market: 91.48% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

EVGN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EVGN. EVGN has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EVGN Financial Highlights

Over the last trailing twelve months EVGN reported a non-GAAP Earnings per Share(EPS) of -3.11. The EPS increased by 41.32% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -58.62%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%104.62%
Sales Q2Q%178.55%
EPS 1Y (TTM)41.32%
Revenue 1Y (TTM)N/A

EVGN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to EVGN. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -2% and a revenue growth 38.71% for EVGN


Ownership
Inst Owners7.68%
Ins Owners1.56%
Short Float %0.3%
Short Ratio0.39
Analysts
Analysts82.5
Price Target8.29 (460.14%)
EPS Next Y-2%
Revenue Next Year38.71%